Director, Division of Therapeutics and Medical Consequences (DTMC)
- Employer
- National Institutes of Health - National Institute on Drug Abuse
- Location
- Rockville, Maryland
- Salary
- Salary commensurate with their qualifications
- Closing date
- Oct 8, 2022
View more
- Sector
- Government
- Job Function
- Other
- Position Type
- Full Time
- Level
- Senior Level
The DTMC Director directs an extramural scientific program of national and international scope within NIDA. This position reports to the NIDA Director and is a "top 5" position. The primary goal of the division is to improve the treatment of substance use disorders through the development of new medications, devices, and behavioral therapies. Improving treatment of infectious diseases in substance use disorder populations is another priority goal of the division. To implement these goals, the Director reviews current programs and develops and implements new initiatives, with a staff of 27 extramural scientists and 3 administrative staff, through a process of meetings with outside advisors, requests for applications and program announcements, contract solicitations and allocation of contract resources for specific projects, collaborations with the pharmaceutical industry, scientific presentations, and publications in the peer-reviewed literature. DTMC manages a grants and contracts portfolio of over $200M per year, including one of the NIH Helping to End Addiction Long-term (HEAL) Initiative’s largest programs.
To learn more about the position, benefits, and application process, please see the full vacancy announcement at https://hr.nih.gov/jobs/search/executive/job-59831. Position open until filled. Applications will begin review by the search committee on September 30, 2022. NIDA, NIH, AND HHS ARE EQUAL OPPORTUNITY EMPLOYERSGet job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert